Pharmacologic Management of Hepatic Encephalopathy.
Clin Liver Dis
; 28(2): 287-296, 2024 05.
Article
en En
| MEDLINE
| ID: mdl-38548440
ABSTRACT
Hepatic encephalopathy is a common cause of morbidity and mortality among patients with decompensated liver cirrhosis. In this article, we review the history, mechanism, and evidence for first-line pharmacologic therapies for hepatic encephalopathy including nonabsorbable disaccharides, antibiotics, and electrolyte management. We also review newer, second-line therapies including polyethylene glycol, albumin, branched-chain amino acids, probiotics and fecal microbiota transplant, zinc, and l-ornithine-l-aspartate.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Encefalopatía Hepática
Idioma:
En
Revista:
Clin Liver Dis
Asunto de la revista:
GASTROENTEROLOGIA
Año:
2024
Tipo del documento:
Article